YOLFTbeta
Optimax Holdings Sdn Bhd

Optimax Holdings Sdn Bhd

0222 · KLSE · Healthcare / Medical Care Facilities

0.495MYR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.495
Open0.495
Day Range0.49 – 0.495
52-Week Range0.495 – 0.697
Volume484.10K
Market Cap274.37M
P/E (TTM)25.25
Forward P/E17.01
EPS0.02
Dividend Yield2.72%
Beta0.12
50-Day Avg0.5184
200-Day Avg0.5456

About

Optimax Holdings Berhad, an investment holding company, engages in the provision of eye specialist services and related products in Malaysia. The company's specialist centers offer a range of treatments relating to eye diseases and disorders, such as cataracts, glaucoma, refractive errors, age-related macular degeneration, diabetic retinopathy, retinal detachment, pterygium, keratoconus, dry eyes, and other eye diseases and disorders. It also provides services for treatment of myopia, amblyopia, and squint eyes for kids; eye examination, ortho-k specialist, and orthoptist services for kids; plastic surgery and aesthetic services; lasik surgery service; refractive surgery, consultation and dispensary, oculoplastic surgery, medical consumable and eye examination services. In addition, the company markets food products; and retails pharmaceuticals, medical, orthopaedic goods, perfumery, cosmetics, and toilet articles. Further, it offers medical services related to ear, nose and throat; specialised medical services food or beverage, food and beverage preparation in market stalls/hawkers and retail sales of other food products. It serves international patients from Indonesia, the Philippines, Singapore, Thailand, Australia, China, Hong Kong, and Japan. Holdings Berhad was founded in 1995 and is headquartered in Kuala Lumpur, Malaysia.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEOMs. Sing Yee Tan
  • Employees0
  • HeadquartersNo.145, Jalan Radin Bagus, Kuala Lumpur, Malaysia, 57000, Malaysia
  • Websitehttps://www.optimax2u.com

Leadership

  • Ms. Sing Yee TanCEO & Non-Independent Executive Director · b. 1988
  • Dr. Boon Hock TanExecutive Deputy Chairman · b. 1956
  • Mr. Woei Yaw PangChief Financial Officer · b. 1989
  • Ms. Chian Yen AngChief Operating Officer · b. 1989

Financials

Income Statement

Currency: MYR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue29.96M36.02M49.23M62.71M58.02M88.90M108.00M114.12M127.69M135.73M
Growth (%)-+20.20%+36.70%+27.36%-7.47%+53.22%+21.49%+5.66%+11.89%+6.30%
Cost of Revenue6.13M8.26M10.55M36.49M12.09M19.47M23.63M70.33M26.12M97.96M
Gross Profit23.84M27.75M38.68M26.21M45.93M69.42M84.37M43.78M101.56M37.77M
Gross Margin79.55%77.06%78.57%41.80%79.16%78.10%78.12%38.37%79.54%27.83%
Operating Expense18.49M17.28M29.66M30.09M34.84M49.77M59.74M22.54M79.05M14.74M
Operating Income5.34M10.48M9.03M-3.88M11.09M19.66M24.63M21.24M22.52M23.03M
Operating Margin17.83%29.09%18.33%-6.18%19.11%22.11%22.80%18.62%17.63%16.97%
EBITDA--14.37M17.89M17.04M26.24M32.55M28.59M37.16M39.52M
EBITDA Margin--29.19%28.53%29.37%29.51%30.14%25.05%29.10%29.12%
Net Income3.24M7.39M4.45M7.83M5.64M12.30M14.69M12.89M13.02M13.75M
Net Income Margin10.81%20.52%9.03%12.49%9.72%13.83%13.60%11.30%10.19%10.13%
Interest Expense001.24M1.46M1.54M1.26M1.23M1.44M2.59M2.90M
Interest Expense % of Total Revenue0.00%0.00%2.53%2.33%2.65%1.42%1.14%1.26%2.03%2.14%

Balance Sheet

Currency: MYR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets32.43M40.27M56.19M63.91M84.23M92.61M101.39M119.74M148.67M148.18M
Total Liabilities20.21M23.93M35.40M39.68M34.01M34.87M39.40M51.78M75.34M75.97M
Total Equity12.22M16.34M20.79M22.66M47.87M55.04M58.12M63.02M67.76M73.64M
Cash2.80M3.20M5.53M6.75M9.84M18.52M18.20M16.16M17.57M21.80M
Total Debt---25.34M26.41M24.08M26.14M33.09M58.88M49.83M
Net Debt--8.39M18.60M16.57M5.56M7.93M16.94M41.31M28.03M

Cash Flow

Currency: MYR2016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow8.29M8.13M12.90M17.66M12.96M19.69M27.05M25.30M23.86M30.60M
Investing Cash Flow-17.76M-3.79M-7.44M-5.11M-19.58M-295.00K-11.24M-9.87M-21.49M-6.84M
Financing Cash Flow6.38M-4.15M-1.83M-11.69M10.79M-10.71M-16.14M-17.47M-311.00K-19.31M
Capital Expenditure17.77M1.95M7.09M4.69M4.56M11.08M11.12M11.32M24.17M5.84M
Free Cash Flow--5.81M12.97M8.40M8.61M15.94M13.49M-313.00K24.76M
Dividends Paid01.08M06.00M5.13M5.13M11.61M9.74M7.58M7.06M
FCF to OCF--45.02%73.44%64.82%43.71%58.91%53.33%-1.31%80.91%
Dividend Paid to FCF--0.00%46.27%61.09%59.60%72.84%72.19%-2423.32%28.53%

Earnings

Report DateSep 2, 2020Dec 2, 2020Mar 3, 2021May 25, 2021Aug 25, 2021Nov 24, 2021Feb 24, 2022May 25, 2022Aug 19, 2022Nov 29, 2022Feb 28, 2023May 26, 2023Aug 24, 2023Nov 29, 2023Feb 28, 2024May 28, 2024Aug 28, 2024Nov 27, 2024Feb 27, 2025May 28, 2025Aug 28, 2025Nov 27, 2025Feb 25, 2026May 26, 2026Aug 20, 2026
EPS Estimate-------------------------
EPS Actual0.000.000.000.000.000.010.010.000.010.010.010.000.010.000.010.010.010.010.010.010.010.010.010.010.01
Surprise-------------------------
Timing--------Pre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap274.37M
Enterprise Value305.62M
Trailing P/E25.25
Forward P/E17.01
PEG Ratio1.00
Price / Sales1.97
Price / Book3.61
EPS0.02
Book Value0.141
Revenue (TTM)139.36M
Gross Profit (TTM)54.05M
EBITDA35.54M
Profit Margin9.31%
Operating Margin17.64%
Return on Equity18.26%
Return on Assets9.36%
Shares Outstanding543.31M
Shares Float145.71M
Beta0.12
Dividend Yield2.72%
Dividend Rate0.01
Payout Ratio60.61%

Dividends

20261×
0.01Mar 13, 2026
20252×
0.01Dec 12, 20250.01Mar 12, 2025
20242×
0.01Dec 10, 20240.01Mar 19, 2024
20232×
0.01Dec 19, 20230.01Mar 20, 2023
20222×
0.01Dec 12, 20220.01Mar 16, 2022
20211×
0.01Dec 9, 2021

Stock Splits

  • May 5, 20222:1